Ameriprise Financial Inc Omeros Corp Transaction History

Ameriprise Financial Inc

$356 Billion
Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Omeros Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 120,477 shares of OMER stock, worth $393,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,477

Previous 120,493 0.01%

Holding current value

$393,959

Previous $1.19 Million 16.81%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$7.04 - $11.21 $112 - $179	-16 Reduced 0.01%	120,477 $990,000
Q4 2024 Feb 14, 2025	BUY	$3.77 - $12.15 $8,735 - $28,151	2,317 Added 1.96%	120,493 $1.19 Million
Q2 2024 Aug 14, 2024	SELL	$3.04 - $4.23 $3,860 - $5,372	-1,270 Reduced 1.06%	118,176 $479,000
Q1 2024 May 15, 2024	BUY	$2.88 - $4.89 $7,862 - $13,349	2,730 Added 2.34%	119,446 $412,000
Q2 2023 Aug 14, 2023	SELL	$4.45 - $7.57 $4,895 - $8,327	-1,100 Reduced 0.93%	116,716 $634,000
Q1 2023 May 15, 2023	SELL	$2.48 - $5.22 $2,852 - $6,003	-1,150 Reduced 0.97%	117,816 $547,000
Q4 2022 Feb 14, 2023	SELL	$1.75 - $3.96 $2,100 - $4,752	-1,200 Reduced 1.0%	118,966 $268,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $7.46 $371,312 - $896,438	120,166 New	120,166 $379,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $8.54 $60,532 - $91,173	-10,676 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $143,058 - $174,018	10,676 New	10,676 $147,000
Q4 2017 Feb 12, 2018	SELL	$13.26 - $22.86 $664,962 - $1.15 Million	-50,148 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$19.76 - $24.9 $990,924 - $1.25 Million	50,148	50,148 $1.08 Million

Others Institutions Holding OMER

# of Institutions

153

Shares Held

28M

Call Options Held

369K

Put Options Held

697K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $205M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Omeros Corp Transaction History